AKT1 and melanoma: Further, higher activation of the AKT survival pathway has been demonstrated in astrocyte‐conditioned medium compared to fibroblast‐conditioned medium and inhibition of PI3K/AKT signalling resensitized melanoma cells isolated from a vemurafenib‐resistant brain metastasis (Niessner et al., 2013).